Pennsylvania 2025-2026 Regular Session Status: In Committee 3 R cosponsors

HB 2747 — An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

Last action — Referred to Judiciary

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced August 25, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Stalled 20% · moderate confidence
  • In Committee

    Current position in the legislative process.

  • 3 sponsors

    1 primary, 2 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (3 R).

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

This bill amends the scheduling of controlled substances under state law.

The bill revises how certain drugs and substances are classified in the state's Controlled Substance Act. This can impact the regulation and control of these substances.

Bill Text

How this bill changes current law

1 change Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill adds synthetic benzimidazole-opioids (Nitazenes) to the Schedule I list of controlled substances in Pennsylvania law.

  • Section 4(1)

    (ix) Any of the following synthetic benzimidazole-opioid (Nitazenes) substances, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers whenever the existence of the isomers, esters, ethers and salts is possible: 1. 2-(2-(4-butoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)-N,N-diethylethan-1-amine (butonitazene). 2. 2-(2-(4-ethoxybenzyl)-1Hbenzimidazol-1-yl)-N,Ndiethylethan-1-amine (etodesnitazene; etazene). 3. N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (flunitazene). 4. N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (metodesnitazene). 5. N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H benzimidazol-1-yl)ethan-1-amine (metonitazene). 6. 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1Hbenzimidazole (N-pyrrolidino etonitazene; etonitazepyne). 7. N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene). 8. N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (isotonitazene).

    This change classifies specific synthetic opioids as Schedule I controlled substances, subjecting them to strict regulation.

Action History

  1. Referred to Judiciary

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 2 co-sponsors · 250 not signed on

Sponsors (1)

Co-sponsors (2)

Not signed on (250)

250 members have not signed on to this bill.

Show all 250 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 2747?
HB 2747 is sponsored by Dan Moul (Republican), Andrew Kuzma (Republican), and Doyle Heffley (Republican).
What is the current status of HB 2747?
This bill is in committee in the House. Introduced August 25, 2026. It must pass committee before a floor vote.
Where can I track HB 2747?
Track HB 2747 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2747

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 2747

Last checked for changes about 1 month ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →